Besides, it could modulate tumor microenvironment, including decrease of immune escape-related cells (myeloid-derived suppressor cells, etc.), increase of tumor killer cells (CD8 + T-lymphocytes, etc.), induction of macrophage M2/M1 phenotype shift, and suppression of VEGF-mediated angiogenesis [16]. The gene discussed is CD8A; the disease is neoplasm.